Table 4.
Parameter | CBD dilatation (%) | Odds Ratio | 95% Confidence Limit | Adjusted P value |
---|---|---|---|---|
Group A vs. group B | 29.1 vs. 9.7 | 3.79 | 1.25–11.45 | < 0.0001 |
MD-IPMN vs. group B | 81.2 vs. 9.7 | 40 | 7.87–200 | < 0.0001 |
BD-IPMN vs. group B | 18.4 vs. 9.7 | 2.1 | 0.64–6.8 | 0.61 |
M-IPMN vs. group B | 28 vs. 9.7 | 3.6 | 0.93–13.89 | 0.25 |
MD-IPMN vs. BD-IPMN | 81.2 vs. 18.4 | 19.23 | 4.81–76.92 | 0.0002 |
MD-IPMN vs. M-IPMN | 81.2 vs. 28 | 11.14 | 2.41–51.41 | 0.01 |
BD-IPMN vs. M-IPMN | 18.4 vs. 28 | 0.58 | 0.2–1.66 | 0.74 |
Post-Hoc testing in the univariate logistic regression, with the Tukey-Kramer correction for multiple testing